Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nuveen Municipal Income ETF (NUMI)

Nuveen Municipal Income ETF (NUMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family NUVEEN NuShares
  • Assets Under Management 25,141,400
  • Shares Outstanding, K 1,000
  • 60-Month Beta N/A
  • Price/Earnings ttm N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.29%

Most Recent Stories

More News
Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change...

NUMI : 25.17 (+0.22%)
CMPS : 4.74 (-5.01%)
SEEL : 0.3900 (-27.79%)
ATAI : 2.13 (-13.06%)
MNMD : 9.26 (-0.86%)
NUMI.TO : 0.0500 (+42.86%)
NUMIF : 0.0320 (-19.19%)
Happy National Holidays

Monday U.S. Economic Lookahead ISM Manufacturing (June) Construction Spending ...

NUMI : 25.17 (+0.22%)
CULP : 5.25 (-0.76%)
SLP : 35.38 (-2.24%)
NUMI.TO : 0.0500 (+42.86%)
RCH.TO : 39.49 (-0.08%)
ATZ.TO : 69.58 (+1.93%)
New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences

A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same transformational effects as a near-death experience (NDE). The study...

NUMI : 25.17 (+0.22%)
HCA : 321.24 (-4.63%)
DRUG : 38.33 (-0.39%)
DRUG.CN : 55.1500 (+0.49%)
LFST : 7.95 (-2.45%)
NUMIF : 0.0320 (-19.19%)
NUMI.TO : 0.0500 (+42.86%)
ACHC : 42.47 (-5.62%)
Colorado to Vote on Legalizing Psychoactives in November

Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the general...

NUMI : 25.17 (+0.22%)
ATAI : 2.13 (-13.06%)
SEEL : 0.3900 (-27.79%)
MNMD : 9.26 (-0.86%)
MMED.NE : 14.9000 (+9.48%)
NUMIF : 0.0320 (-19.19%)
NUMI.TO : 0.0500 (+42.86%)
CYBN : 9.50 (-3.85%)
MDMA Could be a Massive Game-Changer in the Treatment of PTSD

Post-traumatic stress disorder (PTSDF) affects millions of people. In fact, according to The Recovery ...

FTRP.TO : 1.09 (+5.83%)
CYBN : 9.50 (-3.85%)
NUMI.VN : 0.580 (+9.43%)
LKYSF : 0.4800 (-3.63%)
MNMD : 9.26 (-0.86%)
CMPS : 4.74 (-5.01%)
FTRP : 4.2105 (+1.07%)
NUMI : 25.17 (+0.22%)
Stocks in play: Numinus Wellness Inc.

Has finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived Psilocybin ...

NUMI : 25.17 (+0.22%)
Magic Mushrooms Could Be the Biggest Advance for Depression, Says Newsweek

“Magic mushrooms may be the biggest advance in treating depression since Prozac,” says Newsweek. ...

CYBN : 9.50 (-3.85%)
FTRP.TO : 1.09 (+5.83%)
NUMI.VN : 0.580 (+9.43%)
LKYSF : 0.4800 (-3.63%)
MNMD : 9.26 (-0.86%)
FTRP : 4.2105 (+1.07%)
CMPS : 4.74 (-5.01%)
NUMI : 25.17 (+0.22%)
Proactive news headlines including Victory Square Technologies, Altamira Gold, The Parent Company, Loncor Gold and EVmo

New York , July 12, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

YAYO : 0.0001 (unch)
ALTA : 44.16 (-1.25%)
EQTRF : 0.0750 (-5.30%)
GBLEF : 0.0100 (-27.01%)
VST.CN : 0.3600 (-13.25%)
VSQTF : 0.2560 (-12.33%)
KWE : 0.4782 (-2.98%)
KWEMF : 4.9500 (-1.00%)
RCRT : 2.74 (+7.03%)
BETR.CN : 0.1050 (-8.70%)
BETRF : 0.0790 (-25.96%)
BNCHF : 0.4724 (+4.65%)
Proactive news headlines including Else Nutrition, Vanstar Mining, Mawson Gold, Psyched Wellness and CytoDyn

New York , July 06, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

TCF.CN : 0.0550 (+10.00%)
TCFF : 0.2189 (-0.64%)
ALPP : 0.0050 (unch)
PSYC.CN : 0.0250 (unch)
PSYCF : 0.0159 (-0.62%)
IP.CN : 0.0600 (-7.69%)
IPNFF : 0.0462 (+0.43%)
VR.CN : 0.1000 (unch)
VRCFF : 0.0686 (+4.57%)
AGN.CN : 0.1050 (+10.53%)
AGNPF : 0.0803 (+18.61%)
AIR : 67.51 (-0.71%)
Proactive news headlines including Planet 13 Holdings, Numinus Wellness, Plurilock Security, Albert Labs and Byrna Technologies

New York , June 24, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: 

GMBL : 0.2301 (-18.55%)
MVMD.CN : 0.0200 (-20.00%)
EDXC : 0.0090 (unch)
CANN.CN : 0.0050 (unch)
HERTF : 0.0014 (+40.00%)
FANS.CN : 0.260 (+13.04%)
FUNFF : 0.0007 (unch)
BYRN : 27.50 (+3.81%)
BYRN.CN : 30.500 (unch)
GEVO : 1.9750 (+8.52%)
NUMI : 25.17 (+0.22%)
PLTH.CN : 0.5400 (-1.82%)

Fund Summary

The Nuveen Municipal Income ETF seeks to provide high current income exempt from regular federal income taxes. Capital appreciation is a secondary objective when consistent with the Fund's primary objective.

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

3rd Resistance Point 25.20
2nd Resistance Point 25.20
1st Resistance Point 25.18
Last Price 25.17
1st Support Level 25.16
2nd Support Level 25.16
3rd Support Level 25.14

See More

52-Week High 25.19
Last Price 25.17
Fibonacci 61.8% 25.13
Fibonacci 50% 25.11
Fibonacci 38.2% 25.09
52-Week Low 25.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar